Pseudogenes: Between Genomic Fossils and Mapping Pitfalls
Why Is This Important?
Pseudogenes are often introduced as “gene copies that have lost their function,” but they do not constitute a homogeneous group with a single origin or nature. Some arise from the retrotransposition of mRNA back into the genome, while others result from the accumulation of loss-of-function mutations in one copy following gene duplication. In other species, they may remain functional genes but have lost function only within specific lineages.
There are two primary reasons for understanding them: certain loci may be associated with transcription or regulation, and simultaneously, their high sequence similarity to functional genes can interfere with sequencing analysis. It is essential to distinguish biological questions from technical pitfalls.
Core Concepts
Processed pseudogenes typically originate from intron-depleted RNA and often lack the original promoter. Duplicated or unprocessed pseudogenes arise from gene duplication events and may retain exon–intron structure along with portions of surrounding regulatory sequences. A unitary pseudogene refers to a case in which the sole functional copy in a given lineage has lost its function. Annotation databases distinguish these biotypes based on sequence phylogeny and structural features.
The designation pseudo does not necessarily imply that the transcript is non-transcribed or devoid of any role. Some studies have associated pseudogene transcripts with miRNA competition, antisense regulation, or modulation of parent gene expression. However, the mere detection of RNA does not establish physiological function or disease contribution. Locus-specific perturbation and rescue experiments, along with appropriate tissue- and condition-specific reproducibility, are required.
Reasons for Mapping Issues
When short reads align nearly equally to both the parent gene and the pseudogene, aligners struggle to assign them to a single location. Arbitrarily placing these reads or discarding multi-mapping reads can lead to both false positives and false negatives. There is also a risk that variant callers may misinterpret differences in the parent gene as variants in the pseudogene, or vice versa.
This issue cannot be resolved simply by increasing depth, as this may only generate more equally ambiguous reads. Solutions may require locus-specific primers containing unique flanking sequences, tailored alignment strategies, long-range PCR, independent assays, or sufficiently long reads.
Small Analytical Example
Consider a pseudogene P that is highly similar to the functional gene G. If a common base in P coincides with the pathogenic variant position in G, reads derived from P may be misaligned to G, creating false variants. Conversely, true variant reads from G might be missed if they are filtered out due to low mapping quality.
The analyst designs orthogonal confirmation by evaluating mappability of the region, read pair orientation, allele balance, and population artifacts. Reporting only that “coverage is sufficient” is insufficient to assess these risks.
Controls Required in Functional Studies
When measuring pseudogene RNA, it is essential to verify primers and unique sequences that distinguish the target from its parent gene. It is also critical to ensure that knockdown reagents do not simultaneously target both loci. Because overexpression experiments may exceed physiological expression levels, independent rescue from endogenous perturbation provides stronger evidence.
In disease association studies, locus transcription and function, patient phenotype, and causal variants must be documented as distinct claims.
Common Misconceptions
- Pseudogenes are not all genomic fossils formed in the same manner.
- Transcription does not equate to function, and functional potential does not equate to disease causality.
- High coverage does not imply high mappability.
- Long reads are not an automatic solution; their library preparation, read accuracy, and analysis pipelines must be validated.
Limitations
Annotation varies depending on the reference assembly and database release, and pseudogene boundaries or biotypes may be updated. Clinical assays must specify the detection limits and confirmation methods for difficult loci, and should not obscure the residual risk associated with negative results.
Reading in Context
The selection of blind spots for each assay is connected to the advantages and conditions of WGS·WES·panel and long-read sequencing, which are PacBio SMRT and HiFi, while reference coordinate dependency is linked to the concept of the Reference genome.